Viewing Study NCT01338805


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2026-03-04 @ 8:23 PM
Study NCT ID: NCT01338805
Status: COMPLETED
Last Update Posted: 2021-03-05
First Post: 2011-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II BGG492 Capsule Extension for Partial Epilepsy
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module